ConductScience.org, home

Paper37578596

Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.

Karagiannis TC and 11 others. Cell Mol Life Sci, 2023. Cited by 16 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies. Papers, record 37578596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37578596

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies.
PubMed
Journal
Cell Mol Life Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2024-05-16
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Karagiannis TCTom Chttps://orcid.org/0000-0002-9967-1546
2Wall MMeaghan
3Ververis KKatherine
4Pitsillou EEleni
5Tortorella SMStephanie M
6Wood PAPeter A
7Rafehi HHaloom
8Khurana IIshant
9Maxwell SSScott S
10Hung AAndrew
11Vongsvivut JJitraporn
12El-Osta AAssam

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fusion Proteins, bcr-ablMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Humans
Imatinib Mesylate
K562 Cells
Transferrin
Pyrimidines
Drug Resistance, Neoplasm
Histone Deacetylases
Doxorubicin
Receptors, Transferrin
Chromosomes
Mesylates
Apoptosis

Source PubMed

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,681,407The Gene Ontology (GO) database and informatics resource.Nucleic Acids Res2004https://conductscience.org/library/papers/14681407PubMed
237,156,012Broad histone H4 monomethylation marks expressed genes involved in translation.Genome2023https://conductscience.org/library/papers/37156012PubMed
317,020,995
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
Clin Cancer Res2006https://conductscience.org/library/papers/17020995PubMed
420,379,172A global map of human gene expression.Nat Biotechnol2010https://conductscience.org/library/papers/20379172PubMed
5528,075Presence of erythrocytic components in the K562 cell line.Int J Cancer1979https://conductscience.org/library/papers/528075PubMed
62,578,837Increased expression of a novel c-abl-related RNA in K562 cells.Blood1985https://conductscience.org/library/papers/2578837PubMed
719,738,609Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.Br J Cancer2009https://conductscience.org/library/papers/19738609PubMed
820,931,110Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy.Analyst2010https://conductscience.org/library/papers/20931110PubMed
917,079,478Receptor-mediated DNA-targeted photoimmunotherapy.Cancer Res2006https://conductscience.org/library/papers/17079478PubMed
1016,971,499Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.Am J Physiol Cell Physiol2007https://conductscience.org/library/papers/16971499PubMed
1110,075,079A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.Biochem Pharmacol1999https://conductscience.org/library/papers/10075079PubMed
1216,518,375Targeting multidrug resistance in cancer.Nat Rev Drug Discov2006https://conductscience.org/library/papers/16518375PubMed
136,302,135Transferrin receptors in human tissues: their distribution and possible clinical relevance.J Clin Pathol1983https://conductscience.org/library/papers/6302135PubMed
1436,139,405Bioinformatic Analyses of Broad H3K79me2 Domains in Different Leukemia Cell Line Data Sets.Cells2022https://conductscience.org/library/papers/36139405PubMed
1535,884,363Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia.Cancers (Basel)2022https://conductscience.org/library/papers/35884363PubMed
1620,372,103Quantification of gammaH2AX foci in response to ionising radiation.J Vis Exp2010https://conductscience.org/library/papers/20372103PubMed
1717,457,302Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.Nat Rev Cancer2007https://conductscience.org/library/papers/17457302PubMed
186,300,904Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6300904PubMed
1924,348,038Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery.Int J Nanomedicine2013https://conductscience.org/library/papers/24348038PubMed
2011,248,328
Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization.
Leuk Res2001https://conductscience.org/library/papers/11248328PubMed

See all 58 references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42,527,527An AI-enabled structural atlas decodes kinase specificity across the human proteome.Nat Biotechnol2026https://conductscience.org/library/papers/42527527PubMed
42,253,939Epigenetic Regulation in Cardiovascular Diseases: Mechanisms and Therapeutic Targets.MedComm (2020)2026https://conductscience.org/library/papers/42253939PubMed
42,137,270Chemistry-mediated synthetic virus-cell interaction as a generic approach to enhance gene delivery to mammalian cells.Mol Ther Adv2026https://conductscience.org/library/papers/42137270PubMed
41,891,880Accurate prediction of cohesin and RNA Polymerase II-associated chromatin interactions using convolutional neural networks.Nucleic Acids Res2026https://conductscience.org/library/papers/41891880PubMed
41,816,830NSUN2-FOSB reciprocity facilitates leukemogenesis in an m5C-dependent manner by increasing BCL2L1 expression.Haematologica2026https://conductscience.org/library/papers/41816830PubMed
41,497,174Single-cell structural lipidomics using a miniature dual-LIT mass spectrometer.Chem Sci2026https://conductscience.org/library/papers/41497174PubMed
41,063,277Mn-Zn ferrite nanoparticles inducing ferroptosis to reverse the resistance in CML cells.J Transl Med2025https://conductscience.org/library/papers/41063277PubMed
40,923,846Impact of Serum/Xeno-Free Medium and Cytokine Supplementation on CAR-T Cell Therapy Manufacturing in Stirred Tank Bioreactors.Biotechnol J2025https://conductscience.org/library/papers/40923846PubMed
40,726,176Sensitive Detection and Identification Method of Erythrocyte-like Cells upon Doxorubicin Induced Differentiation with Vibrational Techniques.Anal Chem2025https://conductscience.org/library/papers/40726176PubMed
39,263,318Advancements in Chronic Myeloid Leukemia detection: Development and evaluation of a novel QCM aptasensor for use in clinical practice.Biochem Biophys Rep2024https://conductscience.org/library/papers/39263318PubMed
39,033,780Discovery of differentially expressed proteins for CAR-T therapy of ovarian cancers with a bioinformatics analysis.Aging (Albany NY)2024https://conductscience.org/library/papers/39033780PubMed
38,928,414Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation.Int J Mol Sci2024https://conductscience.org/library/papers/38928414PubMed
38,671,192Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.Sci Rep2024https://conductscience.org/library/papers/38671192PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
HDAC99,734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
TFRC7,037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene
TXK7,294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37578596

GET https://conductscience.org/api/papers/v1/37578596/references?page=2